Aerobic degradation of aromatic compounds usually involves their successive activation and modification such that they are channeled toward a few dihydroxylated intermediates (17, 38) . Catechol is the common intermediate during the degradation of a significant number of aromatic compounds such as benzoate, benzene, phenol, or salicylate and can be subject to either intradiol cleavage by a catechol 1,2-dioxygenase (C12O) or extradiol cleavage by a catechol 2,3-dioxygenase (17, 38) . Enzymes for catechol degradation via intradiol cleavage are encoded by the catechol branch of the 3-oxoadipate pathway (15) . Pseudomonas strains usually contain a catRBCA gene cluster (16, 33, 54) comprising genes encoding catechol 1,2-dioxygenase (CatA), muconate cycloisomerase (MCI; CatB), and muconolactone isomerase (CatC), which are controlled by a LysR type regulator (CatR) in response to the inducer muconate (17) . However, various permutations with respect to enzyme distribution, regulation, and gene organization have also been observed (15, 30, 47, 55) . The proteobacterial pathway for catechol degradation is not suited for the degradation of chlorosubstituted or methylsubstituted catechols. Methylcatechols, when channeled into the intradiol pathway, are transformed into methylsubstituted muconolactones as dead-end products (8, 25) . Enzymes involved in 4-methylmuconolactone degradation have thus far been characterized only from Rhodococcus rhodochrous N75 and Cupriavidus necator JMP134 and comprise a 4-methylmuconolactone 4-methylisomerase, forming 3-methylmuconolactone, as a key enzyme (7, 13, 43) . Bacteria capable of degrading chloroaromatics via chlorocatechols usually contain enzymes of the chlorocatechol pathway (48, 49) , involving ortho cleavage by a chlorocatechol 1,2-dioxygenase with high activity against chlorocatechols (11), a chloromuconate cycloisomerase with high activity against chloromuconates (53) , a dienelactone hydrolase active against both cis-and trans-dienelactone (4-carboxymethylenebut-2-en-4-olide) (53) , and a maleylacetate reductase (23) . In phylogenetic analyses, chlorocatechol and catechol 1,2-dioxygenases constitute different subfamilies of the family of intradiol dioxygenases. Chlorocatechol 1,2-dioxygenases are of broad substrate specificity, whereas catechol 1,2-dioxygenases exhibit relatively low activity with 4-chlorocatechol and negligible activity with 3-chlorocatechol (38) . More importantly, muconate and chloromuconate cycloisomerases differ not only in substrate specificity but also in the reaction performed. Chloromuconate cycloisomerases catalyze a dehalogenation of 3-chloromuconate to form cis-dienelactone (53) , and muconate cycloisomerases catalyze the formation of protoanemonin (1) with 4-chloromuconolactone as a reaction intermediate (1, 32) . 2-Chloromuconate is dehalogenated only by chloromuconate cycloisomerases (59) , while mu-conate cycloisomerases form 2-chloro-and 5-chloromuconolactone (60) .
Pseudomonas sp. strain MT1 has been reported to degrade 4-and 5-chlorosalicylate by a different metabolic route (32) . The substrates are transformed by a salicylate 1-hydroxylase into 4-chlorocatechol, which is subject to ring cleavage by catechol 1,2-dioxygenase to yield 3-chloromuconate. It is suggested that trans-dienelactone hydrolase acts on 4-chloromuconolactone as an intermediate in the muconate cycloisomerase-catalyzed transformation of 3-chloromuconate, thus preventing protoanemonin formation in favor of maleylacetate (32) . Maleylacetate is reduced to 3-oxoadipate by maleylacetate reductase. Chlorocatechol degradation in strain MT1 was thus assumed to occur by a pathway consisting of a patchwork of reactions known from the 3-oxoadipate pathway (catechol 1,2-dioxygenase, muconate cycloisomerase), the chlorocatechol pathway (maleylacetate reductase), and a trans-dienelactone hydrolase. However, the kinetic parameters of the characterized muconate cycloisomerase (that is, its preference for 3-chloromuconate over muconate as a substrate) set it apart from previously characterized muconate cycloisomerases (32, 53, 58) . Moreover, salicylate degradation via catechol is usually performed via meta cleavage, and an operon structure comprising genes encoding a LysR type regulator (NahR), a salicylate 1-hydroxylase (NahG), a catechol 2,3-dioxygenase (NahH), and subsequent enzymes of the meta cleavage pathway is usually conserved (2, 9, 63) . However, no extradiol dioxygenase activity was observed in either salicylategrown or chlorosalicylate-grown cells of MT1 (32) , suggesting that the gene encoding salicylate 1-hydroxylase is not clustered with the meta cleavage pathway.
In the current report we analyzed the genetic organization and expression of two catabolic gene clusters of MT1. Detailed characterization of the kinetic parameters of the enzymes encoded revealed that one of the clusters was specifically adapted for channeling substituted salicylates into the catechol ortho cleavage pathway.
MATERIALS AND METHODS
Bacterial strains. Pseudomonas sp. strain MT1 was grown and cell extracts prepared as previously described (32) .
Enzyme assays. Salicylate hydroxylase (SalOH), C12O, catechol 2,3-dioxygenase, and MCI were measured spectrophotometrically as described previously (3, 11, 53, 61) . 4-Methylmuconolactone 4-methylisomerase activity was determined by high-performance liquid chromatography (HPLC) following its transformation into 3-methylmuconolactone (43) . The activities of muconate cycloisomerases MCI catB and MCI salC with 2-chloromuconate (100 M) and 3-chloromuconate were determined by HPLC. As much as 1 U/ml of purified enzymes was used for determining 2-chloromuconate transformation, whereas 3-chloromuconate transformation was determined using 5 to 30 mU/ml (MCI catB ) or 0.2 to 1 mU/ml (MCI salC ) (units were measured with 0.1 mM muconate as a substrate).
Specific activities (units per gram of protein) are expressed as micromoles of substrate converted or product formed per minute per gram of protein at 25°C. Protein concentrations were determined by the Bradford procedure using the Bio-Rad protein assay with bovine serum albumin as a protein standard (4) .
Analysis of kinetic data. V max , k cat , and apparent K m values of C12O's with catechols were determined using 1 to 100 M substrate in air-saturated buffer, and kinetic data were calculated from the initial velocities using the MichaelisMenten equation by nonlinear regression (KaleidaGraph; Synergy Software). Since very low K m values were indicated by this method, kinetic data were finally determined from progress curves obtained from reactions with initial substrate concentrations of 10 M, as previously described for determination of low K m values of catechol 2,3-dioxygenases (20) . The data sets obtained were fit to the Michaelis-Menten equation by nonlinear regression (KaleidaGraph; Synergy Software).
V max , k cat , and apparent K m values of SalOH with NADH were determined using 2 to 100 M NADH and 200 M salicylate in air-saturated buffer, and those with differently substituted salicylates were determined using 200 M NADH and 1 to 100 M substrate. Rate constants of SalOH with 5-chlorosalicylate were also determined from progress curves obtained from reactions with initial substrate concentrations of 10 M. The kinetic parameters of MCI catB and MCI salC with muconate, 2-methylmuconate, and 3-methylmuconate were determined using 5 to 100 M substrate. Transformation of 3-chloromuconate was determined by HPLC analysis at substrate concentrations of 50 M to 500 M. Samples were taken during the reaction time, and protoanemonin formation was directly analyzed by HPLC analysis. At least two independent experiments were performed for each value. K m and V max values were calculated by nonlinear regression to the Michaelis-Menten equation by using KaleidaGraph (Synergy Software). Turnover numbers (k cat values) were calculated assuming subunit molecular masses of 34, 209 4 and was separated by HIC, as described above. Fractions eluting at 0.12 Ϯ 0.04 M and exhibiting high activity against muconate but low activity against 3-methylmuconate (MCI catB ) were pooled, whereas fractions eluting at 0.06 Ϯ 0.06 M and exhibiting relatively high activity against 3-methylmuconate (MCI salC ) were discarded. The pooled fractions were further concentrated by ultracentrifugation and separated by HIC using a linear gradient of (NH 4 ) 2 SO 4 (0.5 M to 0 M) over 17 ml with a flow rate of 0.25 ml/min. Fractions with high activity against muconate but low activity against 3-methylmuconate eluted at 0.14 Ϯ 0.06 M (NH 4 ) 2 SO 4 and were pooled. Fractions eluting at Ͻ0.14 Ϯ 0.06 M (NH 4 ) 2 SO 4 were discarded, since they may contain minor amounts of contaminating MCI salC .
SalOH was further purified by gel filtration using a Superose 12 HR10/10 column (Amersham Pharmacia Biotech) with 20 ml Tris-HCl (50 mM, 100 mM NaCl, pH 7.5) as an eluent with a flow rate of 0.3 ml/min. Two fractions (0.5 ml each) exhibiting high activity with salicylate were pooled.
MCI salC was purified from 5-chlorosalicylate-grown cells as previously described (32) .
Electrophoretic methods. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on a Bio-Rad Miniprotein II apparatus as previously described (26) (20) and scanned using a Fujifilm LAS-1000 charge-coupled device camera. The fluorescence intensity was integrated, and the relative intensities of the bands corresponding to C12O catA , C12O salD , MCI catB , and SalOH were determined using the AIDA 2.1 software package (Raytest Isotopenmessgeräte GmbH).
Amino acid sequencing. N-terminal amino acid sequences were determined as previously described (19) .
DNA isolation and preparation of genome libraries. Genomic DNA of Pseudomonas sp. strain MT1 was isolated with the G NOME DNA kit (BIO 101 Systems). A fosmid library was prepared in pCC1FOS according to the manufacturer's recommendations (Epicentre). Genomic DNA was randomly sheared by pipetting to give approximately 40-kb fragments for ligation into pCC1FOS. Ligated DNA was packaged with MaxPlax Lambda packaging extracts, transduced into Escherichia coli strain EPI300-T1, and spread onto LB agar plates containing 12.5 g/ml chloramphenicol. A total of 282 individual clones were analyzed.
For preparation of the phage library, DNA was partially digested with Sau3AI and size fractionated by ultracentrifugation in a sucrose gradient (51) . After overnight precipitation with polyethylene glycol 6000, the recovered fraction of 4-to 12-kbp DNA fragments was ligated into the BamHI/calf intestine alkaline phosphatase-treated ZAP Express vector (Stratagene). Gigapack III gold packaging extract (Stratagene) was used for packaging the ligated DNA into functional phage particles.
Identification of the cat gene cluster of strain MT1. Part of the catA gene encoding C12O catA was amplified by two rounds of PCR (annealing temperature, 50°C) using primers C12OA-F2 (TGCCGAAGTYCARAAYTTTC) and C12OA-R2 (TTGATCTGSGTGGTCAG), which were designed based on the N-terminal protein sequence and on an alignment of the C12O DNA sequences from Pseudomonas strains, respectively. The fragment generated (approximately 700 bp) was cloned into pGEM-T Easy (Promega), transformed into E. coli XL10-Gold (Stratagene), and sequenced. The fosmid library was screened by PCR (annealing temperature, 59°C) using primers specific for catA (incoA F, CTATCGCATCCTGCGTGACT; incoA R, CCGGGTCGAAGTACGAGT AG). A positive fosmid clone was purified with the FosmidMAX DNA purification kit (Epicentre), and the complete catA sequence was obtained by direct sequencing from the fosmid. Sequence information upstream of the catA gene was obtained by PCR using MT1 genomic DNA, primer coA R1 (GCGAGGT CTTCGATGATGTT) (annealing at positions 127 to 146 of catA), and the degenerate primer Areg R2 (TCDATCATNCKWAGRCAATG) (presumed to anneal to catR in a putative catRBCA operon). The fragment (approximately 2.6 kb) obtained after two rounds of PCR using an annealing temperature of 52.5°C was ligated into the pGEM-T Easy vector (Promega), subsequently cloned into E. coli XL10-Gold cells (Stratagene), and verified by sequencing to comprise part of catR, the complete catBC genes, and part of catA.
Identification of the sal gene cluster. Part of the salC gene, encoding MCI salC , was amplified by PCR (annealing temperature, 45°C) using primers MCI_F1 (CTIGAYGCCIARGGCAARCG) and MCI_R (CRTCCCAITAYTGRTTIAC GTC), which were designed based on conserved muconate cycloisomerase protein sequences (LDAQGKR and DVNQYWD, respectively). The 279-bp fragment generated was subsequently cloned into the TOPO vector (Invitrogen), identified by sequencing as probably encoding part of a muconate cycloisomerase, and used as a template to generate a dioxigenin-labeled probe by applying the PCR DIG labeling mix (Roche).
The phage library was plated onto NZY agar (up to 15 plaques/cm 2 ). After overnight growth at 37°C, plaques were lifted onto a nylon membrane (Hybond Nϩ; Amersham Biosciences), which was then denatured (with 1.5 M NaCl-0.5 M NaOH for 2 min), neutralized (with 1.5 M NaCl-0. Phages were converted into phagemids in the host cells after coinfection with ExAssist helper phage (Stratagene). Excised phagemids were cloned into XLOLR cells in LB medium with kanamycin (50 g/ml). Phagemid DNA was isolated with a NucleoSpin plasmid minikit (Macherey-Nagel). Inserts from three selected clones (3,953 bp, 6,394 bp, and 9,327 bp) were sequenced with custom primers.
DNA sequencing and sequence analysis. PCR products were purified with the QIAquick PCR purification kit and were sequenced using the ABI PRISM BigDye Terminator (version 1.1) ready reaction cycle sequencing kit (Applied Biosystems) and an ABI PRISM 3100 genetic analyzer (Applied Biosystems). Raw sequence data from both strands were assembled with Sequencher software, version 4.0.5 (Gene Codes Corporation). DNA and protein similarity searches were performed using the BLASTN and BLASTP programs from the NCBI website. Alignments were generated with the CLUSTALX 1.8 windows interface of the CLUSTALW program using default values (56) . Phylogenetic trees were constructed using the neighbor-joining algorithm of the CLUSTAL program. Distances were generated using the Kimura matrix, and tree stability was supported through bootstrap analysis (100 replicates). Trees were visualized with TREEVIEW 1.6.6 (34) .
Gene expression studies. Pseudomonas sp. strain MT1 cells were harvested during exponential growth with acetate (8 mM; growth rate, 0.24 h Ϫ1 ), salicylate (2 mM), or 5-chlorosalicylate (2 mM). Samples (7 ml; optical density at 600 nm, 0.15) were immediately transferred to a tube containing 7 ml of RNAprotect (QIAGEN), vortexed, and centrifuged at 2,500 ϫ g for 20 min. RNA was isolated by using a QIAGEN RNeasy minikit. RNA was quantified photometrically at 260 nm, and its integrity was evaluated by electrophoresis in 1.2% agarose. Reverse transcription and quantitative real-time PCR were performed using a QuantiTect SYBR green reverse transcription-PCR (RT-PCR) kit (QIAGEN) for onestep RT-PCR in a Rotor-Gene 2000 real-time PCR machine (Corbett Research). Transcripts of salA, salC, catA, and catB were quantified with the following primer pairs: SalA-F (CGCGCCAAGGGCATCAATACTC), SalA-R (GCTGG AGCGGTCGGAAAGGAAC), SalC-F (CACACCATTTCGCAGCAGACC), SalC-R (ACTGGCGTCCATACCGATCAAG), CatA-F (TCAAAATTTCCCA CACTGCTGA), CatA-R (TGACCGCTTTCCAGAACTCTTC), CatB-F (CCT GAAGATTGCCAAGAGTGGT), and CatB-R (AGTTTGTTCAGGGTGACG AAGG). To correct for differences in the amount of starting material, the ribosomal rpsL gene was chosen as a housekeeping reference gene. The PCR primers used for quantifying rpsL transcripts were rpsL-F (GCAAGCGAATG GTCGACAAGA) and rpsL-R (CGCTGTGCTCTTGCAGGTTGTGA) (12) . Real-time PCRs were carried out in 20-l reaction mixtures containing 50 ng of RNA. The thermal cycling conditions were as follows: 30 min at 50°C for reverse transcription; 15 min at 95°C for initial activation of HotStarTaq DNA polymerase, followed by 40 cycles of 15 s at 94°C, 30 s at 62°C, and 30 s at 72°C. Data collection was performed during each extension phase. Melt curve analysis and gel electrophoresis showed high specificity of primers and negligible formation of primer-dimers during amplification (data not shown). The relative expression ratios are presented as changes in the ratio of gene expression between the target gene and the reference gene (rpsL) compared to noninducing conditions (for acetate-grown cells, this ratio was set at 1). The expression ratios were calculated using REST-RG beta software (37) , with crossing points and amplification efficiencies for each sample obtained from Rotor-Gene 2000 software, version 4.6 (Corbett Research), and were tested for significance by a pairwise fixed reallocation randomization test implemented in REST-RG.
Analytical methods. HPLC was performed with a Lichrospher SC 100 RP8 reversed-phase column (125 by 4.6 mm; Bischoff). Methanol-H 2 O containing 0.1% (vol/vol) H 3 PO 4 was used as the eluant at a flow rate of 1 ml/min. The column effluent was monitored simultaneously at 210, 260, and 280 nm by a diode array detector (Shimadzu). Typical retention volumes using 18% (vol/vol) methanol were as follows: 2-chloro-cis,cis-muconate, 10.5 ml; 3-chloro-cis,cis-muconate, 9.6 ml; cis-dienelactone, 5.2 ml; protoanemonin, 4.9 ml; 4-methylmuconolactone, 1.4 ml; 3-methylmuconolactone, 1.2 ml.
Chemicals. 3-Chloro-and 4-chlorocatechol were obtained from Helix Biotech. 2-Methyl-, 3-methyl-, and 3-chloro-cis,cis-muconate were freshly prepared from 3-methyl-, 4-methyl-, and 4-chlorocatechol, respectively, in Tris-HCl (50 mM, pH 7.5, 2 mM MnCl 2 ) using chlorocatechol 1,2-dioxygenase TetC of Pseudomonas chlororaphis RW71 (44) or partially purified C12O salD free of muconate cycloisomerizing activity. cis-Dienelactone was kindly provided by Walter Reineke (Bergische Universität-Gesamthochschule Wuppertal, Wuppertal, Germany) and Stefan Kaschabeck (TU Bergakademie Freiberg, Freiberg, Germany). Protoanemonin, 4-methylmuconolactone, 3-methylmuconolactone, (ϩ)-muconolactone, cis,cis-muconate, and 2-chloro-cis,cis-muconate were prepared as described previously (1, 39, 42, 46) .
Nucleotide sequence accession number. The nucleotide sequences reported in this study have been deposited in the DDBJ/EMBL/GenBank databases under accession numbers DQ870624 (cat gene cluster) and AY944685 (sal gene cluster).
RESULTS
Genetic analysis of the sal gene cluster. A muconate cycloisomerase, which was characterized by its substrate preference of 3-chloromuconate over muconate, has previously been identified in Pseudomonas sp. strain MT1 (32) . Since this enzyme was assumed to be important for both salicylate and chlorosalicylate degradation by this strain, analysis of the encoding gene region was performed. Inspection of the 9,886-bp sequenced region (Fig. 1) identified eight complete open reading frames (ORFs) and one partial ORF. ORF5, designated salC, encoded an enzyme with a deduced N-terminal sequence identical to that of the previously characterized muconate cycloisomerase (32) . Phylogenetic analysis of the deduced protein (further termed MCI salC ) revealed high sequence homology with proteobacterial muconate cycloisomerases, specifically those of Pseudomonas strains (Fig. 2A) . The deduced product of the downstream salD gene showed high sequence homology sequence with proteobacterial catechol 1,2-dioxygenases (Fig.  2B ). However, a gene encoding a muconolactone isomerase (usually clustered in Pseudomonas strains with genes encoding muconate cycloisomerases and catechol 1,2-dioxygenases (16, 17) could not be localized in the sequenced region. In contrast, salC was preceded by ORFs with high homology to genes encoding salicylate 1-hydroxylases (salA) and permeases of the major facilitator subfamily (salB). The salA gene product showed the highest similarity to nahG gene products, singlecomponent flavoprotein monooxygenases responsible for transforming salicylate produced from naphthalene into catechol (Fig. 2C) , and the salB gene product showed the highest similarity to benK (benzoate transporters) transporters of the major facilitator superfamily (64% identity of the deduced amino acid sequence to the benK gene product of Pseudomonas sp. strain ND6 [28] ). Transcribed divergently toward salA, an ORF putatively encoding a regulatory protein of the LysR family was identified and termed salR2 (Fig. 1) . Phylogenetic analysis revealed that the putative gene product clustered with nahR gene products (Fig. 2D) , which are usually responsive to salicylate (14) . Transcribed convergently toward salR2, a second gene (salR1), putatively encoding a LysR type regulator, was observed and showed homology to NahR regulators. Transcribed convergently toward salD, a putative gene (orf7) encoding a 2-hydroxymuconic semialdehyde hydrolase (60% amino acid identity to TdnF of Pseudomonas putida UCC22 [D85415]) was preceded by an incomplete ORF (orf8) of a putative transporter of the resistance-nodulation-cell division family (56% amino acid identity to the putative transporter PP3302 of P. putida KT2440 [NC_002947]). To analyze if C12O salD , like MCI salC , has properties differing from those of typical proteobacterial enzymes of the 3-oxoadipate pathway, kinetic data were measured for fractions obtained after subsequent anion exchange and HIC of salicylategrown cell extracts (Table 1) . k cat values of 8.7 Ϯ 1.4 s Ϫ1 (C12O catA ) and 7.5 Ϯ 0.8 s Ϫ1 (C12O salD ) were obtained for catechol; these are in the same order of magnitude as those reported for catechol 1,2-dioxygenases from other proteobacteria (24, 31, 52). Like previously characterized proteobacterial catechol 1,2-dioxygenases, both enzymes showed negligible activity with 3-chlorocatechol (5, 10). However, the enzymes differed in their turnover rates for 4-chlorocatechol and especially for 4-methylcatechol, where C12O salD exhibited significantly higher rates (Table 1) . Both enzymes also differed with respect to their apparent K m values. Like other proteobacterial dioxygenases (10, 24, 52), C12O catA showed the highest apparent K m with 4-methylcatechol. This contrasts with C12O salD , which showed relatively low affinity for catechol and 3-methylcatechol ( Table  1 ). The k cat /K m specificity constants indicate that catechol is the preferred substrate for C12O catA whereas 4-methylcatechol is the preferred substrate for C12O salD . Thus, C12O salD shows a substrate specificity profile clearly different from those of previously described C12O's.
Identification of a cat gene cluster in Pseudomonas sp. strain MT1. To analyze if C12O catA is encoded by a typical Pseudomonas catRBCA gene cluster, sequence information (totaling 3,554 bp) was obtained as outlined in Materials and Methods. Analysis of this region revealed three complete ORFs and one partial ORF (Fig. 1) . catA encoded a catechol 1,2-dioxygenase with a deduced N-terminal sequence identical to that identified above for C12O catA . Upstream of catA, two ORFs with high sequence similarity to genes encoding muconolactone isomerase (catC, with 95% identity of the deduced amino acid sequence to the catC gene product of an uncultured bacterium Dendrograms showing the relatedness of muconate cycloisomerases (A), catechol 1,2-dioxygenases (B), salicylate 1-hydroxylases (C), and LysR family regulators similar to NahR (D). The dendrograms were calculated using Treeview 1.6.6 based on sequence alignments calculated by ClustalX 1.81 using the default options. Sequences of deduced proteins of the sal and cat gene clusters of Pseudomonas sp. strain MT1 are boldfaced. Bars correspond to an estimated evolutionary distance of 0.1 amino acid substitution per site. Asterisks indicate bootstrap values of Ͻ50%. The chloromuconate cycloisomerase TfdDI (A) and the chlorocatechol 1,2-dioxygenase TfdCI (B) of C. necator JMP134 and the CatR LysR type regulator (D) of P. putida PRS2000 are included as outgroups. Accession numbers are as follows: for Burkholderia sp. strain NK8 CatB, AB024746; for Burkholderia sp. strain TH2 CatB1, AB035488; for C. necator 335 CatB, AF042281; for P. putida SM25 CatB, AY028997; for P. putida PRS2000 CatB, P08310; for P. putida KT2440 CatB, NC_002947; for P. fluorescens PFO-1 CatB, NC_007492; for Pseudomonas sp. strain CA10 CatB, AB047272; for uncultured bacterium CatB, AB186499; for P. fluorescens Pf-5 CatB, NC_004129; for P. aeruginosa PA01 CatB, NC_002516; for Acinetobacter lwoffii CatB1, O33946; for Frateuria sp. strain ANA18 CatB1, AB009343; for A. lwoffii K24 CatB2, O33949; for Frateuria sp. strain ANA18 CatB2, T48870; for Burkholderia sp. strain TH2 CatB2, AB035325; for Acinetobacter sp. strain ADP1 CatB, Q43931; for C. necator JMP134 TfdDI, P05404; for Frateuria sp. strain ANA18 CatA1, AB009343; for A. lwoffii K24 CatA1, O33948; for Burkholderia sp. strain NK8 CatA, AB024746; for Burkholderia sp. strain TH2 CatA1, AB035483; for P. fluorescens Pf-5 CatA, CP00076; for uncultured bacterium CatA, AB186499; for P. aeruginosa PA01 CatA, NC_002516; for P. putida PRS2000 CatA, U12557; for P. putida KT2440 CatA, NC_002947; for P. fluorescens PfO-1 CatA, CP000094; for Pseudomonas sp. strain CA10 CatA, AB047272; for Acinetobacter sp. strain ADP1 CatA, P07773; for Pseudomonas sp. strain EST1001 PheB, P31019; for Burkholderia sp. strain TH2 CatA2, AB03525; for A. lwoffii K24 CatA2, O33950; for Frateuria sp. strain ANA18 CatA2, AB009373; for C. necator JMP134 TfdCI, P05403; for P. stutzeri AN10 NahR, AF039534; for P. putida KF715 NahR, AY294313; for Pseudomonas pseudoalcaligenes KF707 BphR2, DQ100350; for P. fluorescens NahR, AF491315; for P. putida G7 NahR, P10183; for RT-PCR analysis of MT1 transcripts. To confirm that the sal genes are transcribed during both salicylate and 5-chlorosalicylate degradation, whereas the cat genes are transcribed only during growth on salicylate but not on 5-chlorosalicylate, accumulation of transcripts of salA and salC and of catA and catB was measured during growth on both of these substrates as well as on acetate. Acetate was used as a noninducing negative control, since salicylate 1-hydroxylase activity, as well as catechol 1,2-dioxygenase or muconate cycloisomerizing activity, was in fact absent (Ͻ5 U/g of protein) during growth on this substrate. When the relative expression levels between the target and the reference gene (rpsL) were compared to those under noninducing conditions (at a ratio of 1), significantly higher levels of salA and salC transcripts were observed in salicylate-grown (400-to 800-fold) and specifically in 5-chlorosalicylate-grown cells (approximately 2,000-fold) (Fig. 3) . In contrast, expression of catA and catB genes was observed at significant levels only for salicylate-grown cells (100-to 200-fold), with only slightly elevated levels observed for cells grown with 5-chlorosalicylate (Fig. 3) .
Purification and characterization of muconate cycloisomerases. Since expression analysis indicated that two distinct muconate cycloisomerases were induced during salicylate growth, we attempted to verify this by protein separation. Furthermore, since C12O salD was shown above to be specifically adapted for the turnover of 4-methylcatechol, the turnover of the reaction product 3-methylmuconate by MCI salC was evaluated.
As previously described for 5-chlorosalicylate-grown cells (32), MCI salC eluted at 0.25 Ϯ 0.04 M NaCl during anionexchange chromatography and at 0.06 Ϯ 0.04 M (NH 4 ) 2 SO 4 during HIC. The respective fractions not only were highly active with 3-chloromuconate and transformed it into protoanemonin (32) but also exhibited significantly higher activity with 3-methylmuconate than with muconate (activity with 0.1 mM 3-methylmuconate was approximately 20 times that obtained with 0.1 mM muconate). With salicylate extracts, a separation of two distinct activities against muconate were observed: fractions eluting at 0.6 to 0 M (NH 4 ) 2 SO 4 (MCI salC ) were more active with 3-methylmuconate, and those eluting at 0.18 to 0.08 M (NH 4 ) 2 SO 4 were more active with muconate. Further purification of the aforementioned activity and Nterminal sequencing of the prominent 42-Ϯ 2-kDa band detected by SDS-PAGE (MLATAIESIETIIVD) verified that this was due to induction of MCI catB .
Kinetic data were measured in purified enzyme fractions
Pseudomonas sp. strain KB35B NahR, DQ265742; for P. fluorescens Cg5 NahR, AF491310; for P. putida 9816-4 NahR, AF491307; for Burkholderia gladioli NarR, AF491314 for P. putida Cg1 NahR, AF491308 for P. fluorescens PC20 NarR, AY887963 for Acidovorax sp. strain JS42 NtdR, AY223676 for Ralstonia sp. strain U2 NagR, AF046940 for Burkholderia sp. strain DNT DntR, AY223677 for P. putida PRS2000 CatR, U12557 for Pseudomonas sp. strain KB35 NahG, DQ265742 for P. putida G7 NahG, P23262 for P. putida NCIB9816-4 NahG, AF491307 for P. fluorescens NahG, AY048764 for P. stutzeri AN10 NahG, AF039534 for P. putida KF715 NahG, Q53552 for P. pseudoalcaligenes KF707 SalA, DQ100350 for Pseudomonas sp. strain ND6 NahG (ND016), AY208917 for P. putida S-1 Sal, AB010714 for Acinetobacter sp. strain ADP1 SalA, AF150928 for Burkholderia xenovorans LB400 NahW, CP000272 for Sphingomonas xenophaga P2, AB099984 and for P. stutzeri AN10 NahW, AF039534. a The kinetic constants were determined as described in Materials and Methods using samples where the target protein comprised 41% Ϯ 2% (C12O catA ) or 57% Ϯ 3% (C12O salD ) of the total protein content. Activities were calculated based on the amount of target protein applied and on subunit molecular masses of 34.233 kDa for C12O salD and 34.209 kDa for C12O catA . Standard deviations were calculated with the KaleidaGraph program.
b ND, not determined. (Table  2 ). The observed kinetic constants for MCI catB were highly similar to those previously described for muconate cycloisomerase of P. putida PRS2000 (58): the k cat /K m specificity constants indicated that muconate was the preferred substrate, and the specificity constants with 2-and 3-methylcatechol were approximately 20 to 40% of those with muconate. The activity of MCI catB with 3-chloromuconate was significantly higher than that reported for PRS2000 muconate cycloisomerase. However, it should be noted that, due to the similar spectroscopic properties of 3-chloromuconate and the reaction product protoanemonin (1), such discrepancies may reflect the unsuitability of spectrophotometric methods (such as the photometric test employed by Vollmer et al. [58] ). HPLC analysis revealed that MCI catB transformed 3-chloromuconate nearly quantitatively (90% Ϯ 5%) into protoanemonin, whereas formation of cis-dienelactone was negligible. By using purified MCI salC , the previously analyzed kinetic data with muconate and 3-chloromuconate as substrates (32) could be confirmed. However, our new data indicated that 3-methylmuconate was preferred even over 3-chloromuconate as a substrate (Table 2) . Thus, both enzymes encoded in the sal gene cluster (C12O salD and MCI salC ), which catalyze the turnover of catechols and muconates, were highly adapted toward 4-methylcatechol/3-methylmuconate transformation but also significantly enhanced in their turnover for 4-chlorocatechol/ 3-chloromuconate.
Purification of salicylate hydroxylase. Since two enzymes encoded by the sal gene cluster were shown to be highly adapted for transformation of methylsubstituted substrates, the kinetic properties of salicylate hydroxylase of strain MT1 were also evaluated.
The respective enzyme was purified from salicylate-grown cells by anion-exchange chromatography (eluting at 0.17 Ϯ 0.02 M NaCl) followed by gel filtration. Fractions containing salicylate hydroxylase activity were analyzed by SDS-PAGE, and prominent bands of 48 Ϯ 4 kDa were subjected to Nterminal sequencing. The N terminus of SalOH (NNNSSKQS LRIGXVG, where X is an unknown amino acid) was identical to that of the predicted salA gene product.
Kinetic data were measured in fractions comprising SalOH with a purity of at least 80% of total protein (Table 3 ). The highest turnover numbers were observed with 4-and 5-methylsalicylate. However, when the k cat /K m specificity constants were compared, 5-substituted salicylates were significantly preferred over salicylate as substrates by the enzyme, whereas 3-substituted salicylates were observed to be the less preferred substrates (Table 3) .
Growth on 4-methyl-and 5-methylsalicylate. Since all three catalytic enzymes encoded in the salicylate cluster were highly adapted to the transformation of methylsubstituted substrates, it could be reasoned that the gene cluster has been adapted to channel 4-and 5-methylsalicylate into the ortho cleavage pathway. Strain MT1 was capable of growth on both 4-methyl-and 5-methylsalicylate, with growth rates of 0.49 and 0.45 h Ϫ1 , respectively. These rates are higher than the growth rates reported with 4-chloro-and 5-chlorosalicylate (0.05 h Ϫ1 and 0.16 h Ϫ1 , respectively) and even with salicylate (0.38 h Ϫ1 ) (32). Analysis of cell extracts (Table 4 ) indicated that extradiol cleavage activity was in fact absent in MT1 grown on either of these substrates (Ͻ1 U/g protein), and in the presence of NADH, both 4-and 5-methylsalicylate were transformed quantitatively by cell extracts into 3-methylmuconolactone, as evidenced by HPLC analysis using authentic standards.
The approximately threefold higher intradiol cleavage activities with 4-methylcatechol (compared to catechol) after growth on either 4-or 5-methylsalicylate and the absence of significant activity against muconate in cell extracts (Table 4) indicated that C12O salD and MCI salC , rather than C12O catA and MCI catB , were induced. Separation of enzymes from 4-methylsalicylate-grown cells by HIC confirmed the absence of C12O catA and MCI catB in the cell extract, whereas high activities of C12O salD and MCI salC were present.
Subsequent transformation of 4-methylcatechol by partially purified C12O salD and MCI salC resulted in quantitative formation of 4-methylmuconolactone, as evidenced by HPLC analysis using authentic standards. 4-Methylmuconolactone was a The kinetic constants were determined as described in Materials and Methods using samples where the target protein comprised 85% Ϯ 5% of the total protein content. Activities were calculated based on the amount of target protein applied and on a subunit molecular mass of 50.712 kDa. Standard deviations were calculated with the KaleidaGraph program.
further transformed, by cell extracts, into 3-methylmuconolactone with activities of 80 U/g of protein. This pathway via isomerization of 4-into 3-methylmuconolactone is similar to that previously described for 4-methylcatechol transformation by JMP134 (43) and indicates the presence of a 4-methylmuconolactone 4-methylisomerase in MT1.
DISCUSSION
Catabolic gene clusters in Pseudomonas sp. strain MT1. Pseudomonas sp. strain MT1 has recently been shown to degrade 4-and 5-chlorosalicylate by a pathway that was thought to comprise a patchwork of reactions known from the classical 3-oxoadipate pathway, a trans-dienelactone hydrolase and a maleylacetate reductase (32) . However, we show here that enzymes of the archetypal catRBCA gene cluster of the 3-oxoadipate pathway are not induced in Pseudomonas sp. strain MT1 during the growth of the strain on substituted salicylates. Rather, a new chimeric cluster comprising genes encoding a flavoprotein salicylate 1-hydroxylase and ortho cleavage pathway genes encoding a catechol 1,2-dioxygenase and a muconate cycloisomerase is responsible for channeling various substituted salicylates into ortho cleavage routes.
The genetic organization of various catechol gene clusters (cat genes) has been described previously (15, 16, 36, 54) . The organization of the cat gene cluster of strain MT1 is identical to the organization characteristic for Pseudomonas strains and shows highest similarity to the cluster identified from an environmental metagenome library constructed from petroleumcontaminated groundwater (57) . In MT1, the function of C12O catA and MCI catB is to create, together with muconolactone isomerase, a functional catechol branch of the 3-oxoadipate pathway. This branch is induced during growth on salicylate, probably by muconate, which is generally assumed to interact with the respective CatR regulator of catRBCA operons (15, 35) .
In MT1, two additional catechol pathway genes are located in one gene cluster together with a gene encoding salicylate 1-hydroxylase. Salicylate 1-hydroxylases are usually reported to be encoded in sal operons coding for the conversion of salicylate to tricarboxylic cycle intermediates through the meta cleavage pathway. Exceptionally, as in Pseudomonas stutzeri AN10 (3), a second salicylate 1-hydroxylase gene situated outside of the sal operon has been observed, whereas in Acinetobacter sp. strain ADP1 the gene encoding salicylate 1-hydroxylase is in the same transcription unit, but only with a LysR type regulator (18) . The physical linkage of a salicylate 1-hydroxylase gene with genes encoding enzymes of the ortho cleavage pathway has, to the best of our knowledge, not been observed.
Properties of gene products of the sal gene cluster. Only a few proteobacterial catechol 1,2-dioxygenases have been described in detail for their catabolic properties. In all cases reported to date, catechol is the preferred substrate, as indicated by specificity constants of 30-to 100-fold that of 4-chlorocatechol (10, 52) and 6-to 40-fold that of 4-methylcatechol (10, 52, 62) . C12O salD of MT1 is particular in this respect; its specificity constants for catechol and 4-chlorocatechol are similar, and of the substrates tested, 4-methylcatechol is the preferred substrate.
MCI salC also, compared to previously described proteobacterial enzymes (53, 58) , showed remarkable activities against 3-substituted muconates, with 3-chloromuconate and specifically 3-methylmuconate to be preferred over muconate as substrates. A thorough analysis of the P. putida PRS200-derived cycloisomerase has been performed by Vollmer et al. (58) . Based on known 3-dimensional structures, variants of the cycloisomerase had been constructed by site-directed mutagenesis; an I54V (numbering according to MCI of P. putida PRS2000) derivative showed a significant increase in turnover of 3-chloromuconate, and 3-methylmuconate was the preferred substrate for this derivative (58) . Sequence analysis revealed that MCI salC , but not MCI catB , harbored a valine residue at the appropriate position, in contrast to all other natural proteobacterial gene variants reported thus far. It can therefore be reasoned that this variation is at least partially responsible for the extraordinary substrate specificity of MCI salC . However, compared to the I54V derivative, MCI salC showed a 30-fold higher k cat and a significantly lower affinity with muconate, an effect not reached by any of the site-directed mutants constructed by Vollmer et al. (58) . Further investigations are thus necessary to unravel the underlying reason for MCI salC substrate specificity.
In contrast to MCI salC and C12O salD , SalOH does not differ significantly in kinetic parameters from previously described enzymes. Generally, salicylate 1-hydroxylases have broad substrate specificity and can transform various monosubstituted salicylates (3, 27, 64) . Unfortunately, no thorough investigation on kinetic parameters is available, and generally, only V max values or k cat values are given. Usually, 4-and 5-methylsalicylate are transformed at a higher rate comparable to that of salicylate, whereas 4-and 5-chlorosalicylates are transformed less effectively. Role of the sal gene cluster. In strain MT1, the function of the sal cluster is to effectively funnel 4-and 5-substituted salicylates into the ortho cleavage pathway (Fig. 4) . For 4-and 5-methylsalicylate, transformation by enzymes of this cluster results in the formation of 4-methylmuconolactone (Fig. 4) , a compound previously described as a dead-end product in Pseudomonas strains (8, 25) . Transformation of this compound in C. necator JMP134 (39) and R. rhodochrous N75 (6) , is catalyzed by a 4-methylmuconolactone methylisomerase transforming 4-into 3-methylmuconolactone (7, 43) . This transformation allows a further degradation by muconolactone isomerases, in analogy to the 3-oxoadipate pathway, by abstracting a proton from the C-4 carbon (45) . In fact, an operon comprising both a gene encoding 4-methylmuconolactone methylisomerase and a gene encoding methylmuconolactone isomerase has been identified in JMP 134 (13) , and homologous genes have been identified in Cupriavidus necator H16 (PHG6385, NC_005241). Clearly, MT1 uses a similar pathway for degradation of 4-methylmuconolactone by initially isomerizing it into 3-methylmuconolactone. However, in contrast to the situation with C. necator, which also harbors catechol meta cleavage pathways (21, 22) and is reported to degrade methylaromatics by both intra-and extradiol cleavage (40, 41) , MT1 metabolizes methylsalicylates exclusively via the ortho cleavage pathway (Fig. 4) . A prerequisite for funneling methylaromatics into ortho cleavage pathways is the induction of both a catechol 1,2-dioxygenase and a muconate cycloisomerase during growth on methylaromatics. At least for Pseudomonas MT1, the cat gene cluster is not induced during growth on 4-or 5-methylsalicylate (or on 5-chlorosalicylate). Considering that CatR regulators are usually responsive to muconate (29, 35) , it can be suggested that CatR of MT1 is not responsive, or at least is only poorly responsive, to 3-methylmuconate. Unfortunately, no information is available on detailed effector specificities of CatR proteins.
A similar strain capable of degrading methylbenzoate exclusively via the ortho cleavage pathway was previously obtained only after extensive genetic engineering (50) . The goal of that approach had been to obtain a strain capable of simultaneously degrading both methyl-and chloroaromatics via ortho cleavage routes. Clearly, strain MT1 harbors that capability naturally. For the degradation of chlorosalicylates, strain MT1 has been reported to recruit a trans-dienelactone hydrolase capable of hydrolyzing 4-chloromuconolactone, the unstable intermediate of 3-chloromuconate transformation, thereby preventing the formation of protoanemonin (32) . Identification and localization of the respective gene, which, together with the sal gene cluster and a gene encoding maleylacetate reductase, form a functional pathway for chlorosalicylate degradation, are currently in progress.
